LP
NEO icon

LMR Partners’s NeoGenomics NEO Stock Holding History

LMR Partners’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-12,656
Closed -$85K – 556
2016
Q1 		$85K Buy
+12,656
New +$83.3K 0.01% 362
2014
Q3 		– Sell
-71,181
Closed -$237K – 436
2014
Q2 		$237K Buy
+71,181
New +$237K 0.02% 374

Other funds holding NEO

GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $6.48B AUM 30.25% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EA
Emerald Acquisition Seattle, Washington $51.8B AUM
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

LMR Partners's NEO Position: Q2 2016 in Review

LMR Partners sold out of NeoGenomics (NEO) in Q2 2016, closing a stake of 12,656 shares — an estimated $85K sold.

LMR Partners first reported a position in NEO in Q2 2014 and held it in 2 quarters. The position peaked at $237K in Q2 2014. 155 funds tracked by Wall St. Rank hold NEO as of Q2 2016.

  • LMR Partners reported no remaining NeoGenomics position as of Q2 2016 after selling out during the quarter.
  • LMR Partners sold 12,656 NeoGenomics shares in Q2 2016, an estimated $85K.
  • LMR Partners first reported a position in NeoGenomics in Q2 2014 and held it in 2 quarters.
  • LMR Partners's NeoGenomics position peaked at $237K in Q2 2014.
  • 155 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2016.

Based on LMR Partners's 13F filing for Q2 2016, filed 28 Jul 2016.